Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Therapy01:28

Drug Therapy

The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Drug Administration and Therapy Phases: Overview01:26

Drug Administration and Therapy Phases: Overview

Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
Mania and Antimanic Drugs: Overview01:24

Mania and Antimanic Drugs: Overview

Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as a...
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics01:23

Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics

Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla.  Benzonatate operates peripherally within the respiratory tract by anesthetizing...
Drug Dosage Regimen: Overview01:15

Drug Dosage Regimen: Overview

A drug dosage regimen describes the specific instructions and schedule for administering a drug to a patient. It considers factors such as drug dosage, frequency, route of administration, and duration of treatment. Designing an appropriate dosage regimen for a patient aims to achieve a target drug concentration at the site of action.
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
Intrauterine Drug Delivery Systems01:21

Intrauterine Drug Delivery Systems

Controlled-release systems for intravaginal and intrauterine drug delivery have been developed primarily for the administration of contraceptive steroid hormones. These delivery routes circumvent first-pass hepatic metabolism, thereby enhancing bioavailability and allowing for reduced systemic dosages compared to oral administration. Such approaches contribute to improved therapeutic efficacy and patient compliance, particularly in long-term contraceptive regimens.Intravaginal Drug Delivery...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Blobby is a synaptic active zone assembly protein required for memory in Drosophila.

Nature communications·2025
Same author

[Rehabilitative short-term care (REKUP): acceptance and practicability of a new care concept].

Zeitschrift fur Gerontologie und Geriatrie·2024
Same author

Genetic susceptibility to neurodevelopmental conditions associates with neonatal DNA methylation patterns in the general population: an individual participant data meta-analysis.

medRxiv : the preprint server for health sciences·2024
Same author

Exploring long-term cancer survivors' care experiences and unmet needs: protocol for a qualitative study.

BMC cancer·2024
Same author

[Health economic evaluation of rehabilitative short-term care : Analysis of the costs of geriatric patients with and without rehabilitative short-term care after inpatient hospital stay].

Zeitschrift fur Gerontologie und Geriatrie·2024
Same author

[Endoscopic release of the carpal tunnel using the Agee technique modified by Neumann].

Operative Orthopadie und Traumatologie·2023
Same journal

[The digits-in-noise test in audiological cochlear implant aftercare].

HNO·2026
Same journal

[Complications of acute otitis media].

HNO·2026
Same journal

HNO·2026
Same journal

[Facial fillers: evidence base, anatomical principles, materials, risks, techniques, and future perspectives].

HNO·2026
Same journal

Prevention in otology-the key to lifelong hearing health.

HNO·2026
Same journal

[Bilateral low-frequency hearing loss and tinnitus following spinal anesthesia during a cesarean section].

HNO·2026
See all related articles

Related Experiment Video

Updated: May 20, 2026

Ear Plaster Therapy as a Safe and Effective Treatment for Gestational Vomiting
05:33

Ear Plaster Therapy as a Safe and Effective Treatment for Gestational Vomiting

Published on: August 4, 2023

[Medication therapy during pregnancy].

S Gronau1, A Neumann

  • 1Hals-Nasen-Ohrenklinik, Lukaskrankenhaus Neuss GmbH, Preußenstrasse 84, Neuss, Germany. sgronau@lukasneuss.de

HNO
|July 6, 2012
PubMed
Summary
This summary is machine-generated.

Pregnant women often need medication, but concerns about fetal harm from embryotoxic drugs exist. This review guides safe medical treatment for ear, nose, and throat (ENT) conditions during pregnancy.

More Related Videos

Comprehensive Evaluation of the Effectiveness and Safety of Placenta-Targeted Drug Delivery Using Three Complementary Methods
09:04

Comprehensive Evaluation of the Effectiveness and Safety of Placenta-Targeted Drug Delivery Using Three Complementary Methods

Published on: September 10, 2018

Related Experiment Videos

Last Updated: May 20, 2026

Ear Plaster Therapy as a Safe and Effective Treatment for Gestational Vomiting
05:33

Ear Plaster Therapy as a Safe and Effective Treatment for Gestational Vomiting

Published on: August 4, 2023

Comprehensive Evaluation of the Effectiveness and Safety of Placenta-Targeted Drug Delivery Using Three Complementary Methods
09:04

Comprehensive Evaluation of the Effectiveness and Safety of Placenta-Targeted Drug Delivery Using Three Complementary Methods

Published on: September 10, 2018

Area of Science:

  • Otolaryngology
  • Pharmacology
  • Teratology

Context:

  • High prevalence of medication use during pregnancy (85%).
  • Significant concern regarding medication safety for fetal development (1% of congenital malformations).
  • Uncertainty among ENT surgeons and patients regarding appropriate prescribing practices, leading to obstetrician involvement.

Purpose:

  • To provide evidence-based guidance on the medical treatment of ENT diseases in pregnant patients.
  • To consolidate current knowledge, PubMed research, and regulatory recommendations (Red List, FDA) for safe prescribing.
  • To address the uncertainty surrounding medication use in pregnancy for ENT conditions.

Summary:

  • Reviews medical treatment options for common ear, nose, and throat conditions in pregnant women.
  • Utilizes PubMed research, German Red List, and FDA guidelines to inform recommendations.
  • Highlights the importance of informed decision-making for both patients and healthcare providers regarding medication safety during gestation.

Impact:

  • Aims to improve the management of ENT conditions in pregnant women, minimizing risks to the fetus.
  • Provides a valuable resource for clinicians, particularly obstetricians and ENT specialists, facing prescribing dilemmas.
  • Contributes to safer medication practices during pregnancy, reducing the incidence of drug-related congenital anomalies.